Hormonal Contraception in Postpartum Patients with Gestational Diabetes Mellitus

被引：0

作者：

Ionescu, Cringu Antoniu ^{[1
]}

Navolan, Dan ^{[2
]}

Calin, Alina ^{[3
]}

Matei, Alexandra ^{[4
]}

Bohiltea, Roxana ^{[1
]}

Dimitriu, Mihai ^{[1
]}

Ilinca, Corina ^{[5
,6
]}

Ples, Liana ^{[1
]}

机构：

[1] Carol Davila Univ Med & Pharm, Dept Obstet Gynecol & Neonatol, 37 Dionisie Lupu Str, Bucharest 020021, Romania

[2] Victor Babes Univ Med & Pharm, Dept Obstet Gynecol & Neonatol, 2 Eftimie Murgu Sq, Timisoara 300041, Romania

[3] Dunarea de Jos Univ Galati, 47 Domneasca Str, Galati 800008, Romania

[4] Sf Pantelimon Clin Emergency Hosp, Dept Obstet Gynecol, 340 Pantelimon Rd, Bucharest 021661, Romania

[5] Univ Bucharest, Fac Sociol & Social Work, 4-12 Regina Elisabeta Blvd, Bucharest 030018, Romania

[6] Univ Bucharest, Stat Off, 4-12 Regina Elisabeta Blvd, Bucharest 030018, Romania

来源：

REVISTA DE CHIMIE | 2018年 / 69卷 / 02期

关键词：

Gestational Diabetes Mellitus; contraception; Progestogen-only pill; Levonorgestrel-releasing intrauterine device; WOMEN; RISK;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Gestational Diabetes Mellitus is a severe complication in every pregnancy at risk, influencing the clinical outcome in postpartum evolution and affecting women predisposition to future diabetic pathologies. Our study goal was to determine which type of hormonal or non-hormonal contraception method nondiabetic women with past GDM used in their first 6 months postpartum. Results showed that Progestogen-only pill (40.0%) and Levonorgestrel-releasing intrauterine device (23.1%) were the most used contraceptives. Around 56% of the patients were not satisfied using the Barrier method, whereas 67% of the patients in the less than 25 kg/m(2) BMI group reported adverse events. Special consideration must be applied in order to support obese patients and those perpetuating noxious habits.

引用

页码：478 / 483

页数：6

共 50 条

[21] Early Postpartum Diabetes Screening for Women With Gestational Diabetes Mellitus
Werner, Erika F.
Tarabulsi, Gofran
Han, Christina
Satin, Andrew
OBSTETRICS AND GYNECOLOGY, 2014, 123 : 82S - 82S
[22] Hormonal contraceptive use and risk of gestational diabetes mellitus
Hedderson, Monique M.
Weiss, Noel S.
Williams, Michelle W.
Holt, Victoria L.
Ferrara, Assiamira
DIABETES, 2006, 55 : A417 - A417
[23] Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus
O'Higgins, A. C.
O'Dwyer, V
White, K.
Daly, S. F.
Kinsley, B. T.
Turner, M. J.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 9 - 9
[24] Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus
O'Higgins, A. C.
O'Dwyer, Vicky
O'Connor, Clare
Daly, Sean F.
Kinsley, Brendan T.
Turner, Michael J.
IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 403 - 407
[25] Are Postpartum Women with Gestational Diabetes Mellitus Aware of Their Risk?
Oliveros, Jocelyn
Yukihiro, Donna
Segura, Pamela M.
Lillington, Linda M.
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2015, 44 : S67 - S67
[26] Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus
A. C. O’Higgins
Vicky O’Dwyer
Clare O’Connor
Sean F. Daly
Brendan T. Kinsley
Michael J. Turner
Irish Journal of Medical Science (1971 -), 2017, 186 : 403 - 407
[27] Postpartum lipids and glucose tolerance in gestational diabetes mellitus
Sigal, RJ
DIABETES, 1998, 47 : A50 - A50
[28] Postpartum evaluation of amylin levels, in gestational diabetes mellitus
Kinalski, M
Sledziewski, A
Telejko, B
Mironczuk, K
Kretowski, A
Kinalska, I
DIABETES, 2002, 51 : A433 - A433
[29] Serum resistin in gestational diabetes mellitus and early postpartum
Chen, Danqing
Fang, Qin
Chai, Yun
Wang, Hanzhi
Huang, Hefeng
Dong, Minyue
CLINICAL ENDOCRINOLOGY, 2007, 67 (02) : 208 - 211
[30] Optimizing postpartum care for the patient with gestational diabetes mellitus
Martinez, Noelle G.
Niznik, Charlotte M.
Yee, Lynn M.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (03) : 314 - 321

← 1 2 3 4 5 →